The YouTuber identifies Biomerica as a potential 'hidden gem' in advanced diagnostics for gastrointestinal diseases, citing its new international patents for in-foods technology and the launch of its direct-to-consumer IBS test. Despite cyclical revenue and margins, he believes the company is in the early stages of significant growth due to its R&D and market potential.
“I believe this to be in the early stages of the company's growth story, but it happens to be so early in its story that analysts don't seem to have any projections to work from. But given the patents and the market, I believe this may be a little bit of a hidden gem.” — ▶ 12:00